IB Acquisition Corp. (IBACR) income statement

IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$0.10−0.00 (-3.50%)

Close on Oct 30, 2026Market cap $54.39MP/E –Yield –

IB Acquisition Corp. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q3 2026 2026-06-30	TTM Q2 2026 2026-03-31	TTM Q1 2026 2025-12-31	TTM FY 2025 2025-09-30	TTM Q3 2025 2025-06-30	TTM Q2 2025 2025-03-31	TTM Q1 2025 2024-12-31	TTM FY 2024 2024-09-30	TTM Q3 2024 2024-06-30	TTM Q2 2024 2024-03-31	TTM Q1 2024 2023-12-31	TTM FY 2023 2023-09-30
General & Administrative	1.79	1.34	0.75	0.75	0.68	0.58	0.61	0.52	0.37	0.29	0.09	0.01
Operating Income	-1.79	-1.34	-0.75	-0.75	-0.68	-0.58	-0.61	-0.52	-0.37	-0.29	-0.09	-0.01
Interest Expense	–	–	–	–	–	–	–	-3.03	–	–	–	–
Other Non-Operating Income	1.62	2.80	3.91	5.13	5.40	5.65	–	3.03	–	–	–	–
Pretax Income	-0.17	1.46	3.16	4.38	4.72	5.07	3.79	2.50	1.14	-0.29	-0.09	-0.01
Income Tax Expense	0.23	0.48	0.71	0.97	1.13	1.19	–	0.64	–	–	–	–
Net Income	-0.40	0.99	2.45	3.42	3.59	3.88	2.86	1.87	0.82	-0.29	-0.09	-0.01

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 1587.2%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –